MARYLAND LIFE SCIENCES:

MARYLAND AT MEDICA

Get to Know Maryland

Maryland has its very own ecosystem of life sciences companies, making the state an impressive hub for scientific innovation. Maryland’s life sciences industry not only stands out among other states, but also shines internationally. The Maryland Department of Commerce, along with a delegation of Maryland companies, will represent our state at the MEDICA on November 17-21, 2025. If you’ll be attending, stop by Booth 16F03 or click below to learn more about the leaders behind some life sciences companies that proudly call Maryland home.

Maryland’s Delegation

Get Exclusive Life Sciences Updates

Stay informed on life sciences & general business news in Maryland.

This field is for validation purposes and should be left unchanged.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Connect with the Companies

A delegation of Maryland companies will be attending the MEDICA Conference. Explore the companies and find their contact information here.

BC3 Technologies is a mission-driven medical device company focused on life-saving innovation in trauma care. Based in Baltimore, Maryland, BC3 develops simple and effective tools designed for high-pressure environments where every second matters. Our flagship product, SEAL Hemostatic Wound Spray, is a first-in-class aerosolized hemostatic that rapidly controls external bleeding and requires no training to use. Unlike traditional gauze or powders, SEAL delivers a lightweight, sprayable powder that adheres to irregular wound surfaces and begins working immediately. This makes it ideal for first responders, military personnel, industrial safety teams, and everyday civilians.

Contact: Wayne Grube, CEO

Wayne Grube

Boston Easy Biotech, headquartered in Maryland, USA, is dedicated to advancing rapid diagnostic testing for disease detection and long-term health management. Through its brand Famwell, BEB delivers innovative, FDA-approved solutions spanning respiratory, fertility, and drug-of-abuse testing. Key products include the Famwell Flu A/B Antigen Rapid Test, offering results in under 10 minutes with high sensitivity and specificity, and the Famwell Fentanyl/Norfentanyl Rapid Test, designed for both professional (POC) and at-home (OTC) use with reliable cut-off levels and quick results. BEB also provides a broad range of pregnancy and ovulation tests, multi-drug test cups, and an advanced Lab-on-Chip fluorescence analyzer supporting lipid, glucose, kidney, and liver function testing.

Contact: Boyi Wang, Manager of Business Development

Boyi Wang

Caleo Biotechnologies is advancing a next-generation, patient-derived preclinical platform to overcome the limitations of conventional models in fibrosis, inflammation, and cancer. Our proprietary Organ-Dish™ (OD) technology generates self-organizing, multicellular 3D models directly from patient samples. Each model inherently integrates epithelial, stromal, and immune compartments, replicating the structural and functional complexity of native human tissue. This immune-competent, physiologically relevant platform supports drug screening, mechanistic studies, toxicology, and preclinical validation with greater predictive accuracy than animal models or reductionist organoids.

Contact: Samaneh Kamali, CEO

Samaneh Kamali

GraceMed Solutions, LLC is a trusted provider of high-quality flexible scope components designed and manufactured with precision and durability. Based in Columbia, MD, GraceMed specializes in OEM-quality replacement components for a variety of scopes, such as Olympus, Pentax, Storz, Wolf, and Stryker, ensuring smooth operations and enhanced efficiency for repair centers and other healthcare providers. GraceMed’s core capabilities include reverse engineering endoscope components to match the original form, fit and function with exceptional precision. Through our sister company’s flexible scope repair service, we are able to receive real-time feedback on part performance which is an advantage that sets us apart from other manufacturers and distributors.

Contact: Cathy Young, VP of Sales and Marketing

Cathy Young

Human Biosciences Inc. (HBS) is a U.S.-based pioneer in the advanced wound care industry, renowned for introducing native collagen technology to the global market. Our signature Kollagen™ platform uses 100% non-hydrolyzed Type I collagen with a preserved triple-helical structure, supporting the body’s natural wound healing processes throughout all four phases. FDA-cleared and clinically validated, HBS products—including Medifil® II, SkinTemp® II, and Collatek® Gel—are designed to maintain optimal wound environments through deep penetration, fluid control, and moisture balance. Our solutions are used in hospital, outpatient, over-the-counter, and veterinary settings.

Contact: J.P. Goenka, Director of International Business

KANDIH BioScience provides Toxicology Consulting Services in drug regulatory strategy development. They offer a comprehensive range of services to meet the changing needs of their clients. The company maintains a highly trained team of multi-disciplined professionals that are ready to serve your needs. A multidisciplinary scientific consulting firm that strives to develop innovative solutions. They inspire thinkers from different disciplines to combine their efforts for a common purpose. The small size of their firm enhances their flexibility, efficiency, and effectiveness, all of which translate to reduced costs and greater satisfaction for their clients.

Contact: Harriet Kamendi, CEO

Harriet Kamendi

The LaunchPort™ in Baltimore is the Mid-Atlantic’s leading center for medtech commercialization, comprising of a medical device venture center and ISO-13485 advanced manufacturing facility that supports emerging growth Medtech companies by providing co-location with experienced regulated manufacturing and access to core operational services. It is strategically located near the seven major Capital Region’s medical institutions and the core of the US’s regulatory and research in life sciences. Launchport is attending Medica to establish partnerships with medtech companies and sovereign funds seeking entry into the US market through rigorous customer and partnership discovery.

Contact: Bob Storey, Managing Partner

MedApex Research is a full-service Contract Research Organization (CRO) providing end-to-end clinical trial management for pharmaceutical and medical device companies. Our services cover product market and feasibility research, clinical trial design and execution, data management, and comprehensive regulatory submission support—including FDA 510(k), PMA, and De Novo application filings. For all trials, we ensure full compliance with GCP, GCLP, and HIPAA standards. With expertise across therapeutic areas such as infectious disease, immunology, women’s health, gastroenterology, and oncology, MedApex helps companies efficiently navigate complex regulatory pathways to bring innovative, safe, and effective products to the US market.

Contact: Jenny Xia, Director

Jenny

Monarch Innovation Partners Inc., founded in 2013, is a cutting edge, multi-disciplinary consulting practice that provides proven market and business intelligence and product development consultation for emerging technology solutions and enterprise-level implementation strategies. They work with businesses in the following domains: healthcare delivery system technology platforms; enterprise IT architecture consulting and training; IT product, program and project management research and development of emerging technology platforms. Their product line, the Arabica Blue Smart Benefit Wallet, is the first open-source wallet to successfully implement and test the latest interoperability standards for medical and dental data exchange, enabling care coordination and benefit management between patients and their chosen providers and payers.

Contact: Kimberly Harding, President

Kim.Harding

NEOPATHOLOGY CORP. is a biotechnology research and clinical diagnostics development company, developing a new generation of more accurate and more rapidly reported image-based tissue diagnostics and assays. Beyond making more accurate diagnosis in quicker time, its diagnostics better stratify patients for better treatment and clinical outcomes, enabling precision and personalized medicine. NEOPATHOLOGY’s proprietary assays and diagnostic tests leverage its re-imagined diagnostics platform–––a contemporary end-to-end learning-solution, ONEPATHOLOGY(TM). NEOPATHOLOGY’s proprietary approach standardizes the tissue diagnostic process, employs contemporary deep tissue profiling and spatial biology-enabling imaging technologies, and artificial intelligence powered analytics.

Contact: Paul Aiyetan, CEO & Director of Research, Development and Translation

NeuroIntact is a medical device development company focused on preserving the brain. Established in 2023 and headquartered in Baltimore, MD, they have a strong team of founders, scientists, and engineers from the Maryland area. NeuroIntact’s first proprietary device, VCool™, cools or warms the body through the nasal plexus using a patented cannula and delivery tube. VCool provides Temperature Modulation (TM) to protect brain tissue from damage caused by neuronal injury, cerebral edema, and oxygen deprivation.

Contact: Marc McKenna, Director of Operations and Military Affairs

Marc McKenna

Person Clinic — Where Every Encounter Becomes Evidence. PerSoN Clinic is a U.S.-based digital mental health innovation transforming traditional therapy into a continuous, data-driven, and research-ready system of care. The platform combines AI session transcription, multilingual sentiment analysis, and instant SOAP note generation to deliver documentation and insight in under five minutes. Its membership-based practice model supports sustainable, value-based care, while the PerSoN Community enables anonymous, counselor-moderated peer support between sessions. PerSoN integrates seamlessly with EHRs, wearable devices, and research networks, offering HIPAA and SOC-2 compliant architecture aligned with EU GDPR principles. Built for clinicians, hospitals, and research organizations, PerSoN converts real-world therapy data into structured evidence for outcome measurement and clinical innovation.

Contact: Sarah Iranpor

Sarah Iranpor

Severna Health, founded in 2014 as a pharmaceutical and medical device wholesale distributor, concentrates on hospitals, clinics & healthcare systems across North America with supply chain solutions to overcome disruption and ongoing specialty needs. Through rigorous Quality Systems, Severna Health works to identify, inspect, and match high quality products with Severna clients. Whether a Severna Health product, or a Severna Health vetted regulatory compliant supplier, Severna will work to problem solve supply chain disruption with long term solutions. Severna Health is a SAM certified small business (Cage Code: 8sf88) licensed pharmaceutical and medical device distributor.

Contact: Matt Swift, Managing Partner

Matt Swift

*Attending companies may have utilized ExportMD funded in part through a grant with the U.S. Small Business Administration and in accordance with Section 632 of Public Law 117-328, Maryland’s total STEP program cost is $733,333 of which 75% is Federal Share of $550,000 and Non-Federal Share of $183,333.

A woman working in a lab at Launchport in Baltimore

Maryland’s Life Sciences Sector

A woman working in a lab at Launchport in Baltimore

Life sciences companies need a robust scientific and technical community behind them. Here in Maryland, we call that community our innovation ecosystem, and it’s unlike anything else you’ll find in the U.S. What makes our ecosystem so special? Maryland is home to the FDA, NIH, and two times more federal labs than any other state. Here, find renowned universities, a highly trained scientific workforce, and initiatives designed to bolster innovation and success in life sciences.



Maryland is a Global Gateway

image of Syngene International reps alongside state reps

Thinking about entering the U.S. market? Consider Maryland your gateway to the U.S.A. Our location is centrally located on the East Coast, with next-door access to Washington D.C. and leading federal agencies. And, Maryland’s Global Gateway program makes it easy for foreign companies to locate here to affordably test out the market.

image of Syngene International reps alongside state reps
Paul Matino

Senior Regional Manager – Europe